| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.24B | +10.3% |
| Cost of Revenue | $2.09B | +11.1% |
| R&D Expense | $2.35B | +14.5% |
| SG&A Expense | $1.34B | +13.2% |
| Operating Income | $2.54B | -0.4% |
| Pre-tax Income | $3.14B | -5.8% |
| Income Tax | $626.0M | -8.3% |
| Net Income | $2.51B | -5.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.56B | -4.4% |
| Short-term Investments | $4.45B | +18.9% |
| Current Assets | $18.80B | +9.4% |
| Total Assets | $22.21B | +6.0% |
| Current Liabilities | $13.65B | +34.3% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $14.01B | +11.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.65B | +2.8% |
| Investing Cash Flow | -$748.0M | -21.4% |
| Financing Cash Flow | -$3.83B | -7.1% |
| Stockholders' Equity |
| $8.20B |
| -2.5% |